SAN JOSE, Calif., July 14 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the second quarter ended June 30, 2008, after the close of market on July 29.
VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT
/ 5:00 p.m. ET on July 29. This call will be webcast live for all investors
and archived on the company's website at http://www.vnus.com.
How to Access the Teleconference Webcast
VNUS Medical Technologies Second-Quarter 2008 Teleconference
Tuesday, July 29
2:00 p.m. PT / 5:00 p.m. ET
Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly. In addition to the webcast replay, a phone replay will be available for seven days after the live call at (303) 590-3000, code 11117234#.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com.
|SOURCE VNUS Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved